Open-Label, Long-Term (1 Year) Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia.
Phase of Trial: Phase III
Latest Information Update: 01 Nov 2012
At a glance
- Drugs Pitavastatin (Primary)
- Indications Dyslipidaemias; Hypercholesterolaemia
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Kowa Pharmaceutical
- 26 Jan 2010 Actual end date (Nov 2007) added as reported by ClinicalTrials.gov.
- 26 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Sep 2009 New trial record.